South Dakota Investment Council Lowers Stock Holdings in MetLife, Inc. (NYSE:MET)

South Dakota Investment Council decreased its position in shares of MetLife, Inc. (NYSE:METFree Report) by 3.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 102,948 shares of the financial services provider’s stock after selling 3,600 shares during the period. South Dakota Investment Council’s holdings in MetLife were worth $6,808,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the company. Eley Financial Management Inc raised its position in MetLife by 1.0% during the third quarter. Eley Financial Management Inc now owns 16,348 shares of the financial services provider’s stock valued at $1,028,000 after purchasing an additional 168 shares in the last quarter. Austin Private Wealth LLC raised its position in MetLife by 4.1% during the fourth quarter. Austin Private Wealth LLC now owns 4,367 shares of the financial services provider’s stock valued at $289,000 after purchasing an additional 170 shares in the last quarter. KLCM Advisors Inc. grew its stake in shares of MetLife by 3.6% during the third quarter. KLCM Advisors Inc. now owns 4,920 shares of the financial services provider’s stock valued at $310,000 after buying an additional 171 shares during the last quarter. Highland Capital Management LLC grew its stake in shares of MetLife by 0.3% during the fourth quarter. Highland Capital Management LLC now owns 61,738 shares of the financial services provider’s stock valued at $4,083,000 after buying an additional 180 shares during the last quarter. Finally, RFG Advisory LLC grew its stake in shares of MetLife by 3.2% during the fourth quarter. RFG Advisory LLC now owns 5,924 shares of the financial services provider’s stock valued at $392,000 after buying an additional 181 shares during the last quarter. Hedge funds and other institutional investors own 89.81% of the company’s stock.

MetLife Stock Up 0.2 %

NYSE MET traded up $0.17 during mid-day trading on Wednesday, reaching $72.39. The stock had a trading volume of 1,120,607 shares, compared to its average volume of 3,501,424. MetLife, Inc. has a 1 year low of $48.95 and a 1 year high of $74.68. The stock has a market cap of $52.34 billion, a PE ratio of 39.47, a price-to-earnings-growth ratio of 0.54 and a beta of 1.04. The company has a fifty day moving average price of $71.28 and a 200 day moving average price of $67.02. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.16 and a quick ratio of 0.16.

MetLife (NYSE:METGet Free Report) last announced its quarterly earnings data on Wednesday, January 31st. The financial services provider reported $1.93 earnings per share for the quarter, missing analysts’ consensus estimates of $1.95 by ($0.02). MetLife had a return on equity of 19.48% and a net margin of 2.36%. The firm had revenue of $18.72 billion during the quarter, compared to analysts’ expectations of $18.07 billion. On average, research analysts expect that MetLife, Inc. will post 8.71 earnings per share for the current year.

MetLife Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 11th. Investors of record on Tuesday, May 7th will be issued a $0.545 dividend. This is a positive change from MetLife’s previous quarterly dividend of $0.52. This represents a $2.18 dividend on an annualized basis and a yield of 3.01%. MetLife’s payout ratio is presently 113.66%.

Insider Buying and Selling

In related news, EVP Bill Pappas sold 27,000 shares of the business’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $72.27, for a total value of $1,951,290.00. Following the completion of the transaction, the executive vice president now directly owns 57,768 shares in the company, valued at approximately $4,174,893.36. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other MetLife news, insider Ramy Tadros sold 4,026 shares of MetLife stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total value of $289,469.40. Following the completion of the sale, the insider now owns 146,981 shares of the company’s stock, valued at approximately $10,567,933.90. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Bill Pappas sold 27,000 shares of MetLife stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the completion of the sale, the executive vice president now directly owns 57,768 shares of the company’s stock, valued at approximately $4,174,893.36. The disclosure for this sale can be found here. 0.32% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of research analysts have recently issued reports on MET shares. UBS Group reduced their price objective on MetLife from $87.00 to $82.00 and set a “buy” rating on the stock in a research note on Monday, February 5th. Morgan Stanley raised their target price on MetLife from $80.00 to $82.00 and gave the stock an “overweight” rating in a research note on Monday, April 15th. Piper Sandler raised their target price on MetLife from $74.00 to $85.00 and gave the stock an “overweight” rating in a research note on Friday, April 5th. Keefe, Bruyette & Woods raised their target price on MetLife from $82.00 to $87.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 10th. Finally, Wells Fargo & Company raised their target price on MetLife from $83.00 to $86.00 and gave the stock an “overweight” rating in a research note on Thursday, April 11th. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, MetLife currently has a consensus rating of “Moderate Buy” and a consensus target price of $79.23.

Check Out Our Latest Stock Analysis on MetLife

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Recommended Stories

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.